About the Research

The Clinical Microbiology, Microbiome and Infection Prevention Group conducts translational research at the intersection of clinical microbiology, infectious diseases and infection control. Our overarching goal is to improve patient care through more accurate diagnostics, a deeper understanding of pathogen biology and effective strategies to prevent the spread of infectious diseases.

By integrating clinical expertise with modern molecular methods, we investigate how microorganisms cause disease, spread within healthcare environments and interact with the human microbiome. Our research contributes to the development of evidence-based approaches for diagnostics, surveillance, outbreak investigations and infection prevention.

Human Microbiome and Infectious Diseases
Investigating the role of the human microbiome in health and disease, and how microbial communities influence susceptibility to infection, treatment outcomes and recovery.

Shiga Toxin-Producing Escherichia coli (STEC)
Improving diagnostics, prevention and clinical management of STEC infections through genomic characterization and epidemiological studies.

Staphylococcus aureus
Studying antimicrobial resistance, virulence mechanisms and transmission dynamics, including outbreaks in vulnerable patient populations such as neonatal intensive care units.

Clostridioides difficile
Exploring transmission pathways, virulence factors and infection control measures to reduce the burden of healthcare-associated infections.

Intestinal Protozoan Infections
Assessing the prevalence of diarrhea-causing intestinal protozoa and developing improved molecular diagnostic approaches for accurate detection and surveillance.